心房颤动增加蒽环类药物治疗的癌症患者心力衰竭风险：叠加易感人群的风险因素 - Suppr | 超能文献

Atrial Fibrillation Amplifies Heart Failure Risk in Anthracycline Treated Cancer Patients: Stacking Risk Factors in the Vulnerable.

作者信息

Ilkhanoff Leonard, Atwater Brett, Barac Ana

机构信息

Inova Schar Heart and Vascular, Division of Cardiology, Section of Electrophysiology, Falls Church, Virginia.

Inova Schar Heart and Vascular, Division of Cardiology, Section of Electrophysiology, Falls Church, Virginia.

出版信息

Am J Cardiol. 2024 May 1;218:121-122. doi: 10.1016/j.amjcard.2024.02.017. Epub 2024 Mar 2.

DOI:10.1016/j.amjcard.2024.02.017

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Atrial Fibrillation Amplifies Heart Failure Risk in Anthracycline Treated Cancer Patients: Stacking Risk Factors in the Vulnerable.心房颤动增加蒽环类药物治疗的癌症患者心力衰竭风险：叠加易感人群的风险因素

Am J Cardiol. 2024 May 1;218:121-122. doi: 10.1016/j.amjcard.2024.02.017. Epub 2024 Mar 2.

2

Impact of Atrial Fibrillation on Heart Failure in Patients Treated With Anthracycline Chemotherapy.心房颤动对接受蒽环类化疗患者心力衰竭的影响。

Am J Cardiol. 2024 Jan 15;211:268-274. doi: 10.1016/j.amjcard.2023.11.038. Epub 2023 Nov 18.

3

Prognostic Significance of New-Onset Atrial Fibrillation in Patients With Non-Hodgkin's Lymphoma Treated With Anthracyclines.蒽环类药物治疗的非霍奇金淋巴瘤患者新发房颤的预后意义

Am J Cardiol. 2016 Nov 1;118(9):1386-1389. doi: 10.1016/j.amjcard.2016.07.049. Epub 2016 Aug 12.

4

Anthracycline-Induced Atrial Structural and Electrical Remodeling Characterizes Early Cardiotoxicity and Contributes to Atrial Conductive Instability and Dysfunction.蒽环类药物诱导的心房结构和电重构特征性地表现为早期心脏毒性，并导致心房传导不稳定和功能障碍。

Antioxid Redox Signal. 2022 Jul;37(1-3):19-39. doi: 10.1089/ars.2021.0002. Epub 2022 May 4.

5

Cardiac Anthracycline Accumulation and B-Type Natriuretic Peptide to Define Risk and Predictors of Cancer Treatment-Related Early Diastolic Dysfunction.心脏蒽环类药物蓄积与 B 型利钠肽联合预测癌症治疗相关早期舒张功能障碍的风险及预测因素。

J Pharmacol Exp Ther. 2022 Jun;381(3):266-273. doi: 10.1124/jpet.122.001101. Epub 2022 Mar 24.

6

Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer.儿童癌症后发生蒽环类药物相关充血性心力衰竭患者的羰基还原酶3基因（CBR3）和NAD（P）H：醌氧化还原酶1基因（NQO1）中的基因多态性。

Cancer. 2008 Jun 15;112(12):2789-95. doi: 10.1002/cncr.23534.

7

[Cardiovascular complications of cancers and anti-cancer therapy].[癌症及抗癌治疗的心血管并发症]

Vnitr Lek. 2017 Spring;63(3):200-209.

8

Cardiac toxicity after anthracycline chemotherapy in childhood.儿童蒽环类化疗后的心脏毒性。

Herz. 2000 Nov;25(7):676-88. doi: 10.1007/pl00001982.

9

Exposure to anthracyclines during childhood causes cardiac injury.儿童时期接触蒽环类药物会导致心脏损伤。

Semin Oncol. 2006 Jun;33(3 Suppl 8):S8-14. doi: 10.1053/j.seminoncol.2006.04.019.

10

Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010.1985 年至 2010 年接受乳腺癌或淋巴瘤治疗的患者中蒽环类药物与心力衰竭的相关性。

JAMA Netw Open. 2023 Feb 1;6(2):e2254669. doi: 10.1001/jamanetworkopen.2022.54669.

引用本文的文献

1

Atrial arrhythmias associated with anti-tumor drugs in patients with malignant tumors and type 2 diabetes mellitus.恶性肿瘤合并2型糖尿病患者中与抗肿瘤药物相关的房性心律失常。

Front Oncol. 2025 May 29;15:1598921. doi: 10.3389/fonc.2025.1598921. eCollection 2025.

2

Atrial Fibrillation and Cancer-Epidemiology, Mechanisms, and Management.心房颤动与癌症——流行病学、机制及管理

J Clin Med. 2024 Dec 19;13(24):7753. doi: 10.3390/jcm13247753.